Alvarez-Larran A, Garrote M, Ferrer-Marin F, Perez-Encinas M, et al. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer 2022;128:2441-2448.
PMID: 35417564